Works by Wang, Shunqing

Results: 52
    1

    Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.

    Published in:
    Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00687-8
    By:
    • Zhao, Ke;
    • Lin, Ren;
    • Fan, Zhiping;
    • Li, Zhen;
    • Chen, Xiaoyong;
    • Xuan, Li;
    • Huang, Fen;
    • Xu, Na;
    • Wu, Xiuli;
    • Chen, Shaohua;
    • Sun, Jing;
    • Zhang, Xi;
    • Weng, Jianyu;
    • Li, Yonghua;
    • Li, Yuhua;
    • Lin, Dongjun;
    • Nie, Danian;
    • Wang, Shunqing;
    • Xu, Xiaojun;
    • Zhang, Xiaohui
    Publication type:
    Article
    2

    Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 7, p. e2115991, doi. 10.1001/jamanetworkopen.2021.15991
    By:
    • Yu, Sijian;
    • Fan, Zhiping;
    • Ma, Liping;
    • Wang, Yu;
    • Huang, Fen;
    • Zhang, Qing;
    • Huang, Jiafu;
    • Wang, Shunqing;
    • Xu, Na;
    • Xuan, Li;
    • Xiong, Mujun;
    • Han, Lijie;
    • Sun, Zhiqiang;
    • Zhang, Hongyu;
    • Liu, Hui;
    • Yu, Guopan;
    • Shi, Pengcheng;
    • Xu, Jun;
    • Wu, Meiqing;
    • Guo, Ziwen
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 4, p. 571, doi. 10.1002/ajh.26826
    By:
    • Xu, Wei;
    • Zhou, Keshu;
    • Wang, Tingyu;
    • Yang, Shenmiao;
    • Liu, Lihong;
    • Hu, Yu;
    • Zhang, Wei;
    • Ding, Kaiyang;
    • Zhou, Jianfeng;
    • Gao, Sujun;
    • Xu, Bing;
    • Zhu, Zunmin;
    • Liu, Ting;
    • Zhang, Huilai;
    • Hu, Jianda;
    • Ji, Chunyan;
    • Wang, Shunqing;
    • Xia, Zhongjun;
    • Wang, Xin;
    • Li, Yan
    Publication type:
    Article
    11

    Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01021-x
    By:
    • Wu, Liangliang;
    • Liu, Limin;
    • Zhao, Xin;
    • Zhou, Ming;
    • Fu, Andie;
    • Zhang, Yuping;
    • Yang, Wenrui;
    • Chen, Xiaowei;
    • Mo, Wenjian;
    • Wang, Caixia;
    • Li, Yumiao;
    • Xu, Shilin;
    • Pan, Shiyi;
    • Zhou, Ruiqing;
    • Meng, Fankai;
    • Zhang, Fengkui;
    • Wu, Depei;
    • Wang, Shunqing
    Publication type:
    Article
    12
    13
    14
    15

    Bendamustine in the treatment of patients with indolent non‐Hodgkin lymphoma refractory or relapse to rituximab treatment: An open‐label, single‐agent, multicenter study in China.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 4, p. 551, doi. 10.1002/cncr.34544
    By:
    • Gao, Yan;
    • Liu, Yizhen;
    • Wang, Yafei;
    • Zhang, Qingyuan;
    • Wu, Depei;
    • Ye, Xu;
    • Wu, Jianqiu;
    • Xu, Wei;
    • Zhou, Jianfeng;
    • Yang, Yu;
    • Cen, Hong;
    • Zhang, Feng;
    • Xiang, Ying;
    • Tang, Xiaoqiong;
    • Ding, Kaiyang;
    • Lin, JinYing;
    • Ma, Lei;
    • Wang, Shunqing;
    • Yu, Hao;
    • Zhao, Yang
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01240-4
    By:
    • Zhao, Ke;
    • Lin, Ren;
    • Fan, Zhiping;
    • Chen, Xiaoyong;
    • Wang, Yu;
    • Huang, Fen;
    • Xu, Na;
    • Zhang, Xi;
    • Zhang, Xin;
    • Xuan, Li;
    • Wang, Shunqing;
    • Lin, Dongjun;
    • Deng, Lan;
    • Nie, Danian;
    • Weng, Jianyu;
    • Li, Yonghua;
    • Zhang, Xiaohui;
    • Li, Yuhua;
    • Xiang, A. P.;
    • Liu, Qifa
    Publication type:
    Article
    34

    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01240-4
    By:
    • Zhao, Ke;
    • Lin, Ren;
    • Fan, Zhiping;
    • Chen, Xiaoyong;
    • Wang, Yu;
    • Huang, Fen;
    • Xu, Na;
    • Zhang, Xi;
    • Zhang, Xin;
    • Xuan, Li;
    • Wang, Shunqing;
    • Lin, Dongjun;
    • Deng, Lan;
    • Nie, Danian;
    • Weng, Jianyu;
    • Li, Yonghua;
    • Zhang, Xiaohui;
    • Li, Yuhua;
    • Xiang, A. P.;
    • Liu, Qifa
    Publication type:
    Article
    35
    36
    37
    38
    39

    PASS‐ALL study of paediatric‐inspired versus adult chemotherapy regimens on survival of high‐risk Philadelphia‐negative B‐cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 2, p. 628, doi. 10.1111/bjh.19223
    By:
    • Wang, Zhixiang;
    • Fan, Zhiping;
    • Wu, Zhengwei;
    • Xuan, Li;
    • Li, Xin;
    • Tang, Bingqing;
    • Liu, Yiqian;
    • He, Jiabao;
    • Huang, Kangyu;
    • Zhou, Xuan;
    • Gao, Ya;
    • Wang, Qiang;
    • Li, Xiaofang;
    • Lin, Ren;
    • Xu, Na;
    • Huang, Feng;
    • Wang, Shunqing;
    • Liang, Xingquan;
    • Zhang, Jingdong;
    • Liu, Xiaoli
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data.

    Published in:
    Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00859-5
    By:
    • Yu, Sijian;
    • Huang, Fen;
    • Fan, Zhiping;
    • Xuan, Li;
    • Nie, Danian;
    • Xu, Yajing;
    • Yang, Ting;
    • Wang, Shunqing;
    • Jiang, Zujun;
    • Xu, Na;
    • Lin, Ren;
    • Ye, Jieyu;
    • Lin, Dongjun;
    • Sun, Jing;
    • Huang, Xiaojun;
    • Wang, Yu;
    • Liu, Qifa
    Publication type:
    Article
    50